December 1, 2022

In Silico Evaluation of Phytochemicals From Mangifera Indica Against Type 2 Diabetes Targets: A Molecular Docking and Admet Study

View Full Paper

Ask AI

Bookmark

Mango phytochemicals significantly improve glycemic indices and insulin sensitivity in type 2 diabetes patients, highlighting their potential as therapeutic agents.
Docking studies revealed strong interactions with diabetes-related targets like α-amylase and DPP-4, showing the efficacy of mangifera indica extracts.
This systematic review evaluated 114 studies published between 2000 and 2022, integrating findings from both molecular docking and in vivo assays.
Mango-derived phytochemicals present multitarget actions with fewer side effects compared to traditional synthetic drugs, supporting their use in diabetes management.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This systematic review reveals that phytochemicals from mangifera indica improve glycemic indices in type 2 diabetes, suggesting a multi-target strategy for management.

Cite This Study

Tasnim et al. (2022) studied this question.

synapsesocial.com/papers/68af66dfad7bf08b1eae617b https://doi.org/10.63125/anaf6b94

View Full Paper

Ask AI

Bookmark

Implication

This systematic review reveals that phytochemicals from mangifera indica improve glycemic indices in type 2 diabetes, suggesting a multi-target strategy for management.

In Silico Evaluation of Phytochemicals From Mangifera Indica Against Type 2 Diabetes Targets: A Molecular Docking and Admet Study

Key Points

Discussion

Implication

Cite This Study

In Silico Evaluation of Phytochemicals From Mangifera Indica Against Type 2 Diabetes Targets: A Molecular Docking and Admet Study

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider